Autoimmune radiculoplexus neuropathy under adjuvant nivolumab treatment of a female patient with melanoma

Br J Dermatol. 2020 Jan;182(1):246-247. doi: 10.1111/bjd.18358. Epub 2019 Sep 9.

Authors

T Gambichler¹, L Susok¹, M Fels², C Schneider-Gold², F Hof Zum Berge², E Stockfleth¹, I Ayzenberg^{2

3}

Affiliations

¹ Skin Cancer Center Ruhr-University, Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, St Josef Hospital, Gudrunstraße 56, 44791, Bochum, Germany.
² Department of Neurology, Ruhr-University Bochum, St Josef Hospital, Gudrunstraße 56, 44791, Bochum, Germany.
³ Department of Neurology, Sechenov First Moscow State Medical University, Moscow, Russia.

PMID: 31325163
DOI: 10.1111/bjd.18358

No abstract available

Publication types

Letter

MeSH terms

Female
Humans
Ipilimumab
Melanoma* / drug therapy
Nivolumab / adverse effects
Skin Neoplasms* / chemically induced
Skin Neoplasms* / drug therapy

Substances

Ipilimumab
Nivolumab